交易中 08-10 10:01:16 美东时间
+0.120
+0.60%
Roth MKM analyst Jason Wittes reiterates Fortress Biotech (NASDAQ:FBIO) with a Buy and raises the price target from $15 to $16.
2025-03-11 22:49
Sun Pharma to acquire Checkpoint Therapeutics for $4.10 per share, with potential CVR. FDA approves Unloxcyt, the first PD-L1 blocker for advanced cSCC.
2025-03-10 23:08